nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—Dermatitis perioral—Tretinoin—peripheral nervous system neoplasm	0.0293	0.0343	CcSEcCtD
Amcinonide—Dermatitis perioral—Isotretinoin—peripheral nervous system neoplasm	0.0293	0.0343	CcSEcCtD
Amcinonide—Telangiectasia—Tretinoin—peripheral nervous system neoplasm	0.0282	0.033	CcSEcCtD
Amcinonide—Telangiectasia—Isotretinoin—peripheral nervous system neoplasm	0.0282	0.033	CcSEcCtD
Amcinonide—Acneiform eruption—Tretinoin—peripheral nervous system neoplasm	0.0263	0.0308	CcSEcCtD
Amcinonide—Acneiform eruption—Isotretinoin—peripheral nervous system neoplasm	0.0263	0.0308	CcSEcCtD
Amcinonide—Miliaria—Tretinoin—peripheral nervous system neoplasm	0.0226	0.0265	CcSEcCtD
Amcinonide—Miliaria—Isotretinoin—peripheral nervous system neoplasm	0.0226	0.0265	CcSEcCtD
Amcinonide—Secondary infection—Tretinoin—peripheral nervous system neoplasm	0.0226	0.0265	CcSEcCtD
Amcinonide—Secondary infection—Isotretinoin—peripheral nervous system neoplasm	0.0226	0.0265	CcSEcCtD
Amcinonide—Dermatitis perioral—Alitretinoin—peripheral nervous system neoplasm	0.0222	0.026	CcSEcCtD
Amcinonide—Skin atrophy—Tretinoin—peripheral nervous system neoplasm	0.022	0.0258	CcSEcCtD
Amcinonide—Skin atrophy—Isotretinoin—peripheral nervous system neoplasm	0.022	0.0258	CcSEcCtD
Amcinonide—Telangiectasia—Alitretinoin—peripheral nervous system neoplasm	0.0214	0.025	CcSEcCtD
Amcinonide—Skin striae—Tretinoin—peripheral nervous system neoplasm	0.0209	0.0245	CcSEcCtD
Amcinonide—Skin striae—Isotretinoin—peripheral nervous system neoplasm	0.0209	0.0245	CcSEcCtD
Amcinonide—Acneiform eruption—Alitretinoin—peripheral nervous system neoplasm	0.0199	0.0234	CcSEcCtD
Amcinonide—Dermatitis acneiform—Tretinoin—peripheral nervous system neoplasm	0.0194	0.0228	CcSEcCtD
Amcinonide—Dermatitis acneiform—Isotretinoin—peripheral nervous system neoplasm	0.0194	0.0228	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Tretinoin—peripheral nervous system neoplasm	0.019	0.0223	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.019	0.0223	CcSEcCtD
Amcinonide—Miliaria—Alitretinoin—peripheral nervous system neoplasm	0.0171	0.0201	CcSEcCtD
Amcinonide—Secondary infection—Alitretinoin—peripheral nervous system neoplasm	0.0171	0.0201	CcSEcCtD
Amcinonide—Skin atrophy—Alitretinoin—peripheral nervous system neoplasm	0.0167	0.0195	CcSEcCtD
Amcinonide—Skin striae—Alitretinoin—peripheral nervous system neoplasm	0.0158	0.0186	CcSEcCtD
Amcinonide—Leukoderma—Tretinoin—peripheral nervous system neoplasm	0.0156	0.0183	CcSEcCtD
Amcinonide—Leukoderma—Isotretinoin—peripheral nervous system neoplasm	0.0156	0.0183	CcSEcCtD
Amcinonide—Dermatitis acneiform—Alitretinoin—peripheral nervous system neoplasm	0.0147	0.0173	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0144	0.0169	CcSEcCtD
Amcinonide—Leukoderma—Alitretinoin—peripheral nervous system neoplasm	0.0118	0.0139	CcSEcCtD
Amcinonide—Folliculitis—Tretinoin—peripheral nervous system neoplasm	0.0106	0.0124	CcSEcCtD
Amcinonide—Folliculitis—Isotretinoin—peripheral nervous system neoplasm	0.0106	0.0124	CcSEcCtD
Amcinonide—Folliculitis—Dactinomycin—peripheral nervous system neoplasm	0.00864	0.0101	CcSEcCtD
Amcinonide—Rash pustular—Tretinoin—peripheral nervous system neoplasm	0.00833	0.00976	CcSEcCtD
Amcinonide—Rash pustular—Isotretinoin—peripheral nervous system neoplasm	0.00833	0.00976	CcSEcCtD
Amcinonide—Stinging—Tretinoin—peripheral nervous system neoplasm	0.0082	0.00961	CcSEcCtD
Amcinonide—Stinging—Isotretinoin—peripheral nervous system neoplasm	0.0082	0.00961	CcSEcCtD
Amcinonide—Folliculitis—Alitretinoin—peripheral nervous system neoplasm	0.00801	0.00939	CcSEcCtD
Amcinonide—Tenderness—Tretinoin—peripheral nervous system neoplasm	0.00762	0.00892	CcSEcCtD
Amcinonide—Tenderness—Isotretinoin—peripheral nervous system neoplasm	0.00762	0.00892	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.0076	0.0567	CbGpPWpGaD
Amcinonide—Secondary infection—Epirubicin—peripheral nervous system neoplasm	0.0075	0.00878	CcSEcCtD
Amcinonide—Secondary infection—Doxorubicin—peripheral nervous system neoplasm	0.00694	0.00813	CcSEcCtD
Amcinonide—Dermatitis contact—Tretinoin—peripheral nervous system neoplasm	0.00657	0.00769	CcSEcCtD
Amcinonide—Dermatitis contact—Isotretinoin—peripheral nervous system neoplasm	0.00657	0.00769	CcSEcCtD
Amcinonide—Rash pustular—Alitretinoin—peripheral nervous system neoplasm	0.00631	0.0074	CcSEcCtD
Amcinonide—Stinging—Alitretinoin—peripheral nervous system neoplasm	0.00622	0.00728	CcSEcCtD
Amcinonide—Tenderness—Alitretinoin—peripheral nervous system neoplasm	0.00577	0.00676	CcSEcCtD
Amcinonide—ANXA1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.00545	0.0406	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00538	0.0401	CbGpPWpGaD
Amcinonide—Leukoderma—Epirubicin—peripheral nervous system neoplasm	0.00518	0.00607	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00513	0.0383	CbGpPWpGaD
Amcinonide—Dermatitis contact—Alitretinoin—peripheral nervous system neoplasm	0.00498	0.00583	CcSEcCtD
Amcinonide—Tenderness—Cisplatin—peripheral nervous system neoplasm	0.00492	0.00576	CcSEcCtD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00487	0.0363	CbGpPWpGaD
Amcinonide—Leukoderma—Doxorubicin—peripheral nervous system neoplasm	0.0048	0.00562	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.0047	0.035	CbGpPWpGaD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—peripheral nervous system neoplasm	0.00421	0.0314	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.00398	0.0297	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.00378	0.0282	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00363	0.0271	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00361	0.0269	CbGpPWpGaD
Amcinonide—Folliculitis—Epirubicin—peripheral nervous system neoplasm	0.00351	0.00411	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.00339	0.0253	CbGpPWpGaD
Amcinonide—Folliculitis—Doxorubicin—peripheral nervous system neoplasm	0.00324	0.0038	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.00309	0.023	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00304	0.0226	CbGpPWpGaD
Amcinonide—Rash pustular—Epirubicin—peripheral nervous system neoplasm	0.00276	0.00324	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00275	0.0205	CbGpPWpGaD
Amcinonide—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00272	0.00319	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00263	0.0196	CbGpPWpGaD
Amcinonide—Rash pustular—Doxorubicin—peripheral nervous system neoplasm	0.00256	0.00299	CcSEcCtD
Amcinonide—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00252	0.00295	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00252	0.0188	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00245	0.0183	CbGpPWpGaD
Amcinonide—ANXA1—nerve—peripheral nervous system neoplasm	0.00243	0.328	CbGeAlD
Amcinonide—ANXA1—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00242	0.018	CbGpPWpGaD
Amcinonide—Infection—Topotecan—peripheral nervous system neoplasm	0.00237	0.00278	CcSEcCtD
Amcinonide—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00235	0.00276	CcSEcCtD
Amcinonide—Infection—Tretinoin—peripheral nervous system neoplasm	0.00235	0.00276	CcSEcCtD
Amcinonide—Infection—Melphalan—peripheral nervous system neoplasm	0.00232	0.00272	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.00229	0.0171	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00219	0.0163	CbGpPWpGaD
Amcinonide—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.00218	0.00255	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.0021	0.0157	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00206	0.0154	CbGpPWpGaD
Amcinonide—Pain—Topotecan—peripheral nervous system neoplasm	0.00204	0.00239	CcSEcCtD
Amcinonide—ANXA1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00204	0.0152	CbGpPWpGaD
Amcinonide—Pain—Tretinoin—peripheral nervous system neoplasm	0.00203	0.00238	CcSEcCtD
Amcinonide—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.00238	CcSEcCtD
Amcinonide—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.00201	0.00236	CcSEcCtD
Amcinonide—Pain—Melphalan—peripheral nervous system neoplasm	0.002	0.00234	CcSEcCtD
Amcinonide—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00192	0.00226	CcSEcCtD
Amcinonide—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.00183	0.361	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.00182	0.0136	CbGpPWpGaD
Amcinonide—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.00209	CcSEcCtD
Amcinonide—ANXA1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00178	0.0133	CbGpPWpGaD
Amcinonide—Infection—Vincristine—peripheral nervous system neoplasm	0.00172	0.00202	CcSEcCtD
Amcinonide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00169	0.00198	CcSEcCtD
Amcinonide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00168	0.00197	CcSEcCtD
Amcinonide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00168	0.00197	CcSEcCtD
Amcinonide—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00166	0.00194	CcSEcCtD
Amcinonide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00166	0.00194	CcSEcCtD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.00163	0.0122	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00162	0.0121	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00155	0.0116	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.00154	0.0115	CbGpPWpGaD
Amcinonide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.0018	CcSEcCtD
Amcinonide—Infection—Cisplatin—peripheral nervous system neoplasm	0.00152	0.00178	CcSEcCtD
Amcinonide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00151	0.00176	CcSEcCtD
Amcinonide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00149	0.00175	CcSEcCtD
Amcinonide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00149	0.00175	CcSEcCtD
Amcinonide—Pain—Vincristine—peripheral nervous system neoplasm	0.00148	0.00173	CcSEcCtD
Amcinonide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00147	0.00173	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00141	0.0105	CbGpPWpGaD
Amcinonide—Infection—Etoposide—peripheral nervous system neoplasm	0.00139	0.00163	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00135	0.0101	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.00133	0.00992	CbGpPWpGaD
Amcinonide—Pain—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00153	CcSEcCtD
Amcinonide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00149	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.00127	0.00944	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00123	0.00921	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.0012	0.00898	CbGpPWpGaD
Amcinonide—Pain—Etoposide—peripheral nervous system neoplasm	0.0012	0.00141	CcSEcCtD
Amcinonide—ANXA1—trigeminal ganglion—peripheral nervous system neoplasm	0.00118	0.159	CbGeAlD
Amcinonide—ANXA1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00118	0.00878	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.00116	0.00862	CbGpPWpGaD
Amcinonide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00133	CcSEcCtD
Amcinonide—ANXA1—parotid gland—peripheral nervous system neoplasm	0.00111	0.15	CbGeAlD
Amcinonide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00109	0.00128	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00108	0.00805	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00107	0.00797	CbGpPWpGaD
Amcinonide—Fluticasone furoate—ABCB1—peripheral nervous system neoplasm	0.00107	0.21	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.00105	0.00782	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00105	0.0078	CbGpPWpGaD
Amcinonide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000992	0.00116	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000989	0.00738	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000988	0.00737	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000986	0.00735	CbGpPWpGaD
Amcinonide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000964	0.00113	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000958	0.00714	CbGpPWpGaD
Amcinonide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000883	0.00104	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000852	0.00636	CbGpPWpGaD
Amcinonide—NR3C1—nerve—peripheral nervous system neoplasm	0.000846	0.114	CbGeAlD
Amcinonide—ANXA1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000833	0.00621	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000819	0.00611	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000812	0.00605	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.0008	0.00597	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000798	0.00596	CbGpPWpGaD
Amcinonide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000781	0.000915	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00078	0.00582	CbGpPWpGaD
Amcinonide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000723	0.000847	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000697	0.0052	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000685	0.00511	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000672	0.00502	CbGpPWpGaD
Amcinonide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000672	0.000788	CcSEcCtD
Amcinonide—Prednisone—ABCB1—peripheral nervous system neoplasm	0.000651	0.128	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000633	0.00472	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000631	0.00471	CbGpPWpGaD
Amcinonide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.000729	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00061	0.00455	CbGpPWpGaD
Amcinonide—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.0006	0.118	CrCbGaD
Amcinonide—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.000588	0.116	CrCbGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000585	0.00436	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000582	0.00434	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.000581	0.00433	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000578	0.00431	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000568	0.00424	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EED—peripheral nervous system neoplasm	0.00056	0.00418	CbGpPWpGaD
Amcinonide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000556	0.000652	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000554	0.00413	CbGpPWpGaD
Amcinonide—ANXA1—cerebellum—peripheral nervous system neoplasm	0.000515	0.0694	CbGeAlD
Amcinonide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000603	CcSEcCtD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.000514	0.00383	CbGpPWpGaD
Amcinonide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000495	0.00058	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.000474	0.00354	CbGpPWpGaD
Amcinonide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000537	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000448	0.00334	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000437	0.00326	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	0.000418	0.00312	CbGpPWpGaD
Amcinonide—NR3C1—trigeminal ganglion—peripheral nervous system neoplasm	0.00041	0.0552	CbGeAlD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.00039	0.00291	CbGpPWpGaD
Amcinonide—NR3C1—parotid gland—peripheral nervous system neoplasm	0.000387	0.0521	CbGeAlD
Amcinonide—ANXA1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000385	0.00287	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000374	0.00279	CbGpPWpGaD
Amcinonide—NR3C1—brainstem—peripheral nervous system neoplasm	0.000363	0.0489	CbGeAlD
Amcinonide—ANXA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000357	0.00266	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	0.000356	0.00266	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	0.000353	0.00263	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.000342	0.0673	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000327	0.00244	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000231	0.00173	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000227	0.0017	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00018	0.00134	CbGpPWpGaD
Amcinonide—NR3C1—cerebellum—peripheral nervous system neoplasm	0.000179	0.0241	CbGeAlD
Amcinonide—ANXA1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000169	0.00126	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000165	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000163	0.00122	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000149	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000137	0.00102	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000129	0.000959	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000127	0.00095	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000105	0.00078	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.0001	0.000746	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.83e-05	0.000659	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—peripheral nervous system neoplasm	6.19e-05	0.000462	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—peripheral nervous system neoplasm	4.29e-05	0.00032	CbGpPWpGaD
